viewAnteris Technologies Ltd

Admedus completes placement to strategic cornerstone investor Star Bright Group

The latest investment takes Star Bright’s total interest in the company to 19.99% of issued shares.

ASX building
Admedus is also negotiating a long-term funding agreement with Star Bright

Admedus Limited (ASX:AHZ) has completed the placement of more than 70 million shares to Hong Kong-based significant investor Star Bright Group.

The latest investment takes Star Bright’s total interest in the company to 19.99% of issued shares for a total investment of almost $7.7 million.

READ: Admedus secures strategic cornerstone investor from Hong Kong

The placement follows Star Bright’s recent subscription for shares valued at $500,000 as part of an Admedus placement in May 2018 and another placement raising almost $4.26 million, issued on August 22, 2018.

Admedus is also negotiating with Star Bright in respect of a long-term funding agreement for Admedus Immunotherapies.

In this regard, the company has entered an MOU for a 60% share of the vaccines business for an initial investment of $18 million

Quick facts: Anteris Technologies Ltd

Price: 4.01 AUD

Market: ASX
Market Cap: $23.7 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Anteris Technologies Ltd named herein, including the promotion by the Company of Anteris Technologies Ltd in any Content on the Site, the...


Admedus CEO in New York to update on recent key milestones

Admedus Ltd (ASX:AHZ) CEO Wayne Paterson visited the Proactive Investors New York studio to update on key milestones the company has achieved in the past few months, including receiving European approval on two of its products.

on 03/17/2019

2 min read